InsiderInsights.com Daily Round Up 6/30/15: Flaherty & Crumrine Preferred Securities Income, Gyrodyne Company Of America, Everyday Health

|
Includes: ADBE, CATB, CLMS, DHIL, EVDY, FFC, FUND, GIII, GPP, GYRO, HRG, ILMN, IMMY-OLD, LJPC, LPG, RTRX, SEM, SSD, WIN
by: InsiderInsights
Summary

Tables of the top insider purchases and sales filed with the SEC on 6/30/15, based on dollar value.

Dollar values often do not equate with significance when it comes to insider trades.

Proprietary Insider Company Ratings are relayed to clarify significance.

Dollar value is only one metric to assess the significance of an insider transaction, but when high dollar value intersects with significance it spotlights a stock investors should take the time to consider. InsiderInsights Daily Round Up articles are intended as initial research tools, so investors can separate real insider investment intelligence from time-wasting noise.

Click the Company Name links in the tables below to analyze a company's or insider's full insider history.

On Today's Tables:

Insider trades were rated Significant at :

  • Gyrodyne Co Of America (NASDAQ:GYRO), and;
  • Flaherty & Crumrine Preferred Securities Income (NYSE:FFC).

Insider trades were rated Nearly Significant at:

  • Everyday Health (NYSE:EVDY).

Insider trades were considered Insignificant at:

  • Windstream (NASDAQ:WIN);
  • La Jolla Pharm (NASDAQ:LJPC);
  • Simpson Manufacturing Co (NYSE:SSD);
  • Sprott Focus Trust (NASDAQ:FUND);
  • Calamos Asset (NASDAQ:CLMS);
  • Select Medical (NYSE:SEM);
  • Retrophin (NASDAQ:RTRX);
  • Dorian Lpg (NYSE:LPG);
  • Illumina (NASDAQ:ILMN);
  • G III Apparel (NASDAQ:GIII);
  • Diamond Hill Investment (NASDAQ:DHIL), and;
  • Adobe Systems (NASDAQ:ADBE).

There is a Conflicted Insider Signal (both purchases & sales) at:

  • Imprimis Pharm (NASDAQ:IMMY-OLD), and;
  • HRG (NYSE:HRG).

There is an IPO or Known Corporate Action at:

  • Green Plains Partners (NASDAQ:GPP), and;
  • Catabasis Pharm (NASDAQ:CATB).

It's difficult to argue significance for most transactions made during IPOs, or when insiders make trades during a known corporate action.

Insider Purchases

#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1 Clarus Lifesciences BO Catabasis Pharm CATB JB* $4,520,340
2 Medimmune Ventures BO Catabasis Pharm CATB JB* $2,681,268
3 Tang Kevin C DIR,BO La Jolla Pharm LJPC JB* $2,593,470
4 Becker Todd A CEO,DIR Green Plains Partners GPP B $562,500
5 Calamos John P CB,CEO,BO Calamos Asset CLMS B $428,180
6 George Whitney FO,DIR,BO Sprott Focus Trust FUND B $359,865
7 Lamb Paul L DIR Gyrodyne Co Of America GYRO JB* $278,625
8 Opaleye Mgt BO Imprimis Pharm IMMY B $276,500
9 Ettinger Robert M O F&C Pr Sec Inc FFC B $275,250
10 Fletcher John P VP,GC Windstream WIN B $264,000

Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes :
B =Open-market Buy; AB=10b5-1 (automatic) Buy; JB*=Buy indicated as being open-market, but not confirmed by trading price range and volume for the session.

Insider Sales

#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1 Harbinger Capital BO HRG HRG JS*,S $85,512,434
2 Valueact DIR Adobe Systems ADBE S $25,427,160
3 North Tide Capital BO Select Medical SEM S $7,428,763
4 Revolution Wf BO Everyday Health EVDY AS $3,490,618
5 Miller Wayne S COO G III Apparel GIII S $3,139,670
6 Seacor Inc New BO Dorian Lpg LPG S $2,301,000
7 Walt David R DIR Illumina ILMN AS $2,176,449
8 Simpson Psb Fund O Simpson Manufacturing SSD S $2,057,775
9 Shih Alvin VP Retrophin RTRX AS $912,850
10 Dillon Roderick H Jr CEO,DIR Diamond Hill Inv DHIL S $778,486

S =Open-market Sale; AS=10b5-1 (automatic) Sale; JS*=Sale indicated as being open-market, but not confirmed by trading price range and volume for the session.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.